Cargando…
Review: immunosuppression for the lung transplant patient
Lung transplantation (LTx) has evolved significantly since its inception and the improvement in LTx outcomes over the last three decades has predominantly been driven by advances in immunosuppression management. Despite the lack of new classes of immunosuppression medications, immunosuppressive stra...
Autores principales: | Kotecha, Sakhee, Ivulich, Steven, Snell, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662512/ https://www.ncbi.nlm.nih.gov/pubmed/34992841 http://dx.doi.org/10.21037/jtd-2021-11 |
Ejemplares similares
Ejemplares similares
-
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021) -
Lung transplantation: a comprehensive journey
por: D’Cunha, Jonathan
Publicado: (2021) -
Viral infections in lung transplantation
por: Munting, Aline, et al.
Publicado: (2021) -
Fungal infections in lung transplantation
por: Samanta, Palash, et al.
Publicado: (2021) -
Bacterial infections in lung transplantation
por: McCort, Margaret, et al.
Publicado: (2021)